|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-9-4
|
|
pubmed:abstractText |
As more and more postmenopausal women are taking soy isoflavone supplementation for relieving menopausal symptoms, we investigated the impact of chronic exposure on their bioavailability, with focus on achievable plasma concentrations and potential stimulation of the capacity to produce equol.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0954-3007
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Published online 15 February 2006.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1039-45
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16482068-Administration, Oral,
pubmed-meshheading:16482068-Aged,
pubmed-meshheading:16482068-Area Under Curve,
pubmed-meshheading:16482068-Biological Availability,
pubmed-meshheading:16482068-Dietary Supplements,
pubmed-meshheading:16482068-Equol,
pubmed-meshheading:16482068-Female,
pubmed-meshheading:16482068-Genistein,
pubmed-meshheading:16482068-Humans,
pubmed-meshheading:16482068-Isoflavones,
pubmed-meshheading:16482068-Middle Aged,
pubmed-meshheading:16482068-Postmenopause,
pubmed-meshheading:16482068-Soybeans,
pubmed-meshheading:16482068-Time Factors
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
|
|
pubmed:affiliation |
CHRU Clermont-Ferrand, Service Urologie, Clermont-Ferrand, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
